Dantrium (Dantrolene Capsules) and Moxetumomab pasudotox
Determining the interaction of Dantrium (Dantrolene Capsules) and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: Dantrium
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrium (Dantrolene Capsules)-Moxetumomab Pasudotox-tdfk
- Dantrium (Dantrolene Capsules)-Moxetumomab pasudotox-tdfk Intravenous
- Dantrium (Dantrolene Capsules)-Moxifloxacin
- Dantrium (Dantrolene Capsules)-Moxifloxacin (Systemic)
- Dantrium (Dantrolene Capsules)-Moxifloxacin Hydrochloride
- Dantrium (Dantrolene Capsules)-Moxifloxacin Injection
- Moxetumomab pasudotox-Dantrium (Dantrolene Injection)
- Moxetumomab pasudotox-Dantrium Intravenous
- Moxetumomab pasudotox-Dantrolene
- Moxetumomab pasudotox-Dantrolene Capsules
- Moxetumomab pasudotox-Dantrolene Injection
- Moxetumomab pasudotox-Dantrolene Intravenous